Prostate cancer cases ( N = 32 ) were either detected on a biopsy performed for cause or at the end of the study per trial protocol , and controls ( N = 50 ) , defined as negative for cancer on an end-of-study biopsy performed per trial protocol ( e.g. , irrespective of indication ) , were sampled .